ArticleNature communications2025

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.